10-K Decoder · All companies

Kyverna Therapeutics, Inc.

KYTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$170M−$143M−19.1%
Net income−$161M−$127M−26.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 12, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$42.9M−$38.7M−10.9%
Net income−$41.9M−$36.8M−13.9%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Kyverna's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Kyverna profitable in FY2025?
No: net income was −$161M and operating income −$170M in FY2025.
What was Kyverna's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 12, 2026.